Insomnia: Clinical Trials

9 trials for Insomnia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 2 unknown, 1 not yet recruiting. 9 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 19Completed 3, Recruiting 3, Unknown 2, Not yet recruiting 1

Follow Insomnia: new trials by email Literature Review of Insomnia trials Research Report on Insomnia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With Heart-Kidney Non-interaction Syndrome
Qingxin Jiaotai Decoction, Placebo - Insomnia, Obesity
Early Phase 1Not yet recruitingFohow Pharmaceutical Group722026-10-012026-08-10
CBTi for the Treatment of Insomnia in Type 1 Diabetes
Sleep quality improvement therapy, Healthy Living - Diabetes Mellitus Type 1, Insomnia
Early Phase 1RecruitingUniversity of Illinois at Chicago152025-12-012026-10-06
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study
Inhaled Melatonin (100 μg), Oral Melatonin (4 mg) - Insomnia
Early Phase 1UnknownWoolcock Institute of Medical Research52025-07-012025-07-18
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study
Inhaled Melatonin (100 μg), Oral Melatonin (4 mg) - Insomnia
Early Phase 1RecruitingWoolcock Institute of Medical Research102025-07-012025-07-18
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
Cognitive Behavioral Treatment for Insomnia (CBT-I), Trazodone, Placebo - Insomnia, Insomnia Chronic
Early Phase 1RecruitingMilton S. Hershey Medical Center6002024-03-202025-11-10
Feasibility of a Personalized SMS Intervention for Insomnia
SMS Personalized Sleep Intervention - Insomnia, Sleep Disorder
Early Phase 1UnknownUniversity of Missouri, St. Louis502021-11-152022-04-25
Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms
Aspirin, Placebo - Insomnia
Early Phase 1CompletedBeth Israel Deaconess Medical Center82014-10-012017-03-15
Treatments for Insomnia in Patients With Parkinson's Disease
Light box (Litebook company), CBT and sleep hygiene, Doxepin and Zopiclone - Parkinson's Disease, Insomnia
Early Phase 1CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre202011-01-012015-04-16
Usefulness of Shirodhara for Insomnia
Shirodhara Oil Treatment - Insomnia
Early Phase 1CompletedSouthern California University of Health Sciences102008-01-012012-09-20

Narrower conditions

Sleep Initiation and Maintenance Disorders (9)  ·  Sleep Wake Disorders (2)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Obesity (1)  ·  Pain (1)  ·  Parkinson Disease (1)

Broader conditions

Dyssomnias (9)  ·  Mental Disorders (9)  ·  Nervous System Diseases (9)  ·  Sleep Disorders, Intrinsic (9)  ·  Sleep Wake Disorders (7)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Neurologic Manifestations (3)  ·  Nutritional and Metabolic Diseases (2)  ·  Autoimmune Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Body Weight (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Melatonin (2)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Aspirin (1)  ·  Doxepin (1)  ·  Trazodone (1)  ·  zopiclone (1)

Sponsors

Woolcock Institute of Medical Research (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Fohow Pharmaceutical Group (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Milton S. Hershey Medical Center (1)  ·  Southern California University of Health Sciences (1)  ·  University of Illinois at Chicago (1)  ·  University of Missouri, St. Louis (1)

Countries

United States (5)  ·  Australia (2)  ·  Canada (2)  ·  China (1)

Top investigators

Hui Xin Ong, PhD (2)  ·  Ron Grunstein, MBBS MD PhD FRACP (2)  ·  Alexandros Vgontzas, MD (1)  ·  Chelsey R Wilks, PhD (1)  ·  Monika Haack, PhD (1)  ·  Ronald Postuma, MD, MSc (1)  ·  Sivarama P Vinjamury, MAOM (1)

NIH funding

1UG3HL161342-01A1 (1)